Metabolic syndrome and risk of cardiovascular disease: a meta-analysis.

By A. Galassi, K. Reynolds, Jiang He. American Journal of Medicine, 2006

1,222 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Pathophysiology of human visceral obesity: an update. (2013, background): “For the time being, although meta-analyses have shown that metabolic syndrome increases relative risk of type 2 diabetes and CVD (154, 173, 177, 382), it cannot be used as a CVD risk estimate but rather as a tool to emphasize the need to target excess abdominal adiposity by proper lifestyle habits (”
Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome. (2015, background): “This, together with the posible progression to organ failure and of the development of some ancer types, including primary liver cancer [9,11,18,19], makes etabolic syndrome a relevant condition in clinical practice and a ajor public health concern worldwide.”
Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysis (2015, background): “In the general population, these clustered risk factors have been associated with the development of CVD and excess mortality (13-15).”
Chronic Inflammation in Obesity and the Metabolic Syndrome (2010, background): “[4] A.”